These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12150897)

  • 1. Amplifying mechanisms of lymphomagenesis.
    Roth DB
    Mol Cell; 2002 Jul; 10(1):1-2. PubMed ID: 12150897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal location targets different MYC family gene members for oncogenic translocations.
    Gostissa M; Ranganath S; Bianco JM; Alt FW
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2265-70. PubMed ID: 19174520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.
    Yan CT; Kaushal D; Murphy M; Zhang Y; Datta A; Chen C; Monroe B; Mostoslavsky G; Coakley K; Gao Y; Mills KD; Fazeli AP; Tepsuporn S; Hall G; Mulligan R; Fox E; Bronson R; De Girolami U; Lee C; Alt FW
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7378-83. PubMed ID: 16670198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.
    Frank KM; Sharpless NE; Gao Y; Sekiguchi JM; Ferguson DO; Zhu C; Manis JP; Horner J; DePinho RA; Alt FW
    Mol Cell; 2000 Jun; 5(6):993-1002. PubMed ID: 10911993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetramerization and DNA ligase IV interaction of the DNA double-strand break repair protein XRCC4 are mutually exclusive.
    Modesti M; Junop MS; Ghirlando R; van de Rakt M; Gellert M; Yang W; Kanaar R
    J Mol Biol; 2003 Nov; 334(2):215-28. PubMed ID: 14607114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
    Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
    Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 deficiency fails to prevent increased programmed cell death in the Bcl-X(L)-deficient nervous system.
    Klocke BJ; Latham CB; D'Sa C; Roth KA
    Cell Death Differ; 2002 Oct; 9(10):1063-8. PubMed ID: 12232794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine 271 but not lysine 210 of XRCC4 is required for the nuclear localization of XRCC4 and DNA ligase IV.
    Fukuchi M; Wanotayan R; Liu S; Imamichi S; Sharma MK; Matsumoto Y
    Biochem Biophys Res Commun; 2015 Jun; 461(4):687-94. PubMed ID: 25934149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.
    Zhu C; Mills KD; Ferguson DO; Lee C; Manis J; Fleming J; Gao Y; Morton CC; Alt FW
    Cell; 2002 Jun; 109(7):811-21. PubMed ID: 12110179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoubiquitination of the nonhomologous end joining protein XRCC4.
    Foster RE; Nnakwe C; Woo L; Frank KM
    Biochem Biophys Res Commun; 2006 Mar; 341(1):175-83. PubMed ID: 16412978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV.
    Critchlow SE; Bowater RP; Jackson SP
    Curr Biol; 1997 Aug; 7(8):588-98. PubMed ID: 9259561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Terminal region of DNA ligase IV drives XRCC4/DNA ligase IV complex to chromatin.
    Liu S; Liu X; Kamdar RP; Wanotayan R; Sharma MK; Adachi N; Matsumoto Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):173-8. PubMed ID: 23994631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity.
    Modesti M; Hesse JE; Gellert M
    EMBO J; 1999 Apr; 18(7):2008-18. PubMed ID: 10202163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC4 controls nuclear import and distribution of Ligase IV and exchanges faster at damaged DNA in complex with Ligase IV.
    Berg E; Christensen MO; Dalla Rosa I; Wannagat E; Jänicke RU; Rösner LM; Dirks WG; Boege F; Mielke C
    DNA Repair (Amst); 2011 Dec; 10(12):1232-42. PubMed ID: 21982441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of DNA ligase IV on the fidelity of end joining in human cells.
    Smith J; Riballo E; Kysela B; Baldeyron C; Manolis K; Masson C; Lieber MR; Papadopoulo D; Jeggo P
    Nucleic Acids Res; 2003 Apr; 31(8):2157-67. PubMed ID: 12682366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains.
    Grawunder U; Zimmer D; Lieber MR
    Curr Biol; 1998 Jul; 8(15):873-6. PubMed ID: 9705934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro.
    Lee JW; Yannone SM; Chen DJ; Povirk LF
    Cancer Res; 2003 Jan; 63(1):22-4. PubMed ID: 12517771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron microscopy of Xrcc4 and the DNA ligase IV-Xrcc4 DNA repair complex.
    Recuero-Checa MA; Doré AS; Arias-Palomo E; Rivera-Calzada A; Scheres SH; Maman JD; Pearl LH; Llorca O
    DNA Repair (Amst); 2009 Dec; 8(12):1380-9. PubMed ID: 19837014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.
    Ahnesorg P; Smith P; Jackson SP
    Cell; 2006 Jan; 124(2):301-13. PubMed ID: 16439205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells.
    Grawunder U; Wilm M; Wu X; Kulesza P; Wilson TE; Mann M; Lieber MR
    Nature; 1997 Jul; 388(6641):492-5. PubMed ID: 9242410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.